CK Life Sciences Intl (Holdings) Inc

Chart & Performance

D1W1MN

P/E

225.65

P/S

0.73

EPS

0.00

Div Yield, %

1.98%

Shrs. gr., 5y

—

Rev. gr., 5y

0.34%

Revenues

5.32b

+0.89%

Net income

17m

-86.93%

CFO

514m

+41.39%

Dividend

May 23, 20230.008 HKD/sh

Profile

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.

URL

https://www.ck-lifesciences.com/

IPO date

Jul 16, 2002

Employees

1,887

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	5,322,733 0.89%	5,275,590 -2.35%	5,402,312 9.30%
Cost of revenue	3,966,375	3,946,213	4,091,898
Unusual Expense (Income)
NOPBT	1,356,358	1,329,377	1,310,414
NOPBT Margin	25.48%	25.20%	24.26%
Operating Taxes	51,334	72,912	75,438
Tax Rate	3.78%	5.48%	5.76%
NOPAT	1,305,024	1,256,465	1,234,976
Net income	17,250 -86.93%	131,963 -18.94%	162,801 30.00%
Dividends	(76,889)	(96,111)	(96,111)
Dividend yield	1.29%	1.27%	1.35%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	1,221,780	3,125,914	1,293,108
Long-term debt	5,217,489	3,335,920	5,496,011
Deferred revenue
Other long-term liabilities	9,701	8,142	11,409
Net debt	3,886,671	5,721,553	5,892,525
Cash flow
Cash from operating activities	514,181	363,659	423,575
CAPEX	(287,676)	(216,969)	(217,248)
Cash from investing activities	(67,961)	(22,119)	(257,884)
Cash from financing activities	(477,953)	(515,340)	(220,081)
FCF	1,178,527	1,419,056	1,278,773
Balance
Cash	676,163	704,125	902,470
Long term investments	1,876,435	36,156	(5,876)
Excess cash	2,286,461	476,502	626,478
Stockholders' equity	1,079,707	3,277,929	3,145,793
Invested Capital	9,050,355	9,575,590	10,058,631
ROIC	14.01%	12.80%	12.21%
ROCE	13.08%	12.94%	12.01%
EV
Common stock shares outstanding	9,611,073	9,611,073	9,611,073
Price	0.62 -21.52%	0.79 6.76%	0.74 -16.85%
Market cap	5,958,865 -21.52%	7,592,748 6.76%	7,112,194 -16.85%
EV	9,845,536	15,620,464	14,929,474
EBITDA	1,590,099	1,560,291	1,557,298
EV/EBITDA	6.19	10.01	9.59
Interest	322,425	163,092	97,823
Interest/NOPBT	23.77%	12.27%	7.47%